Pain Management During Uterine Artery Embolization for Symptomatic Uterine Fibroids

Lampmann, L. E. H.; Lohle, Paul N.M.; Smeets, Albert J.; Boekkooi, Peter F.; Vervest, Harry A.M.; Oirschot, Charlotte M. van; Bremer, Robbert C.

doi:10.1007/s00270-007-9069-7

Cited by 13 publications

(9 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…4 -6 Post-procedural pain control after UAE remains a major problem. 7 Pelvic cramping most likely due to postembolization myometrial ischaemia and fibroid infarction causes this pain. 8 Even if successful outpatient UAE has been described, it requires an effective pain treatment such as epidural analgesia or high doses of i.v.…”

Section: Accepted For Publication: 14 January 2011mentioning

confidence: 99%

See 1 more Smart Citation

Remifentanil patient-controlled analgesia effect-site target-controlled infusion compared with morphine patient-controlled analgesia for treatment of acute pain after uterine artery embolization

Lipszyc

Winters

Engelman

et al. 2011

British Journal of Anaesthesia

View full text Add to dashboard Cite

show abstract

Section: Accepted For Publication: 14 January 2011mentioning

confidence: 99%

“…8 Even if successful outpatient UAE has been described, it requires an effective pain treatment such as epidural analgesia or high doses of i.v. opioids, 7 mostly morphine which requires sometimes overnight hospitalization. 9 In the study by Kim and colleagues, 10 99% of the women required i.v.…”

Section: Accepted For Publication: 14 January 2011mentioning

confidence: 99%

Remifentanil patient-controlled analgesia effect-site target-controlled infusion compared with morphine patient-controlled analgesia for treatment of acute pain after uterine artery embolization

Lipszyc

Winters

Engelman

et al. 2011

British Journal of Anaesthesia

View full text Add to dashboard Cite

show abstract

“…Serious complications may appear even at 6 months post-treatment (11,13,14,31). Any alterations in inflammatory parameters, body temperature or leukocytosis, along with CRP levels and pain evaluation, should be monitored until 6 months post-embolization (11,13,14,(31)(32)(33)(34)(35)(36). CRP is an acute-phase pro-inflammatory cytokine, which is crucial in the acute phase of inflammation and increases progressively in association with the inflammatory process (11,13,14,(31)(32)(33)(34)(35)(36).…”

Section: Discussionmentioning

confidence: 99%

Significance of changes in inflammatory parameters following uterine artery embolization in pre‑menopausal females

et al. 2020

View full text Add to dashboard Cite

The purpose of the present study was to describe the course of changes in laboratory inflammatory markers following bilateral uterine artery embolization (UAE) as a treatment for leiomyomas and adenomyosis. The body temperature was measured and blood samples were collected to determine white blood cell (WBC) count and C-reactive protein (CRP) levels in 270 patients on the day prior to UAE and for up to 4 days post-embolization. Aside from a single case with a non-inflammatory complication, none of the other cases had any complications. Post-UAE leukocytosis with a mean maximum value of 10.8±3.5x10 9 /l (range, 5.9-18.6x10 9 /l) was observed one-year post-intervention. The mean leukocyte numbers were indicated to be higher on day 3 post-UAE. The CRP level was also increased post-UAE, with a mean maximum value of 7.75±3.5 mg/dl. Maximum levels were reached in 8 patients on the 2nd and in 11 patients on the 3rd post-operative day. The maximum pain score was ~5.5 and reached its lowest level at the end of the 12th week post-intervention. The present study did not consider an association between the embolic material used or uterus size with the level of treatment success. No complications were observed post-UAE; however, a significant increase in the WBC count was observed within the first 3 days, indicating mild leukocytosis.

show abstract

“…Many regimes for analgesia have been proposed, with analgesics being administered before or during the procedure, together with procedural sedation or even general anesthesia [42][43][44]. Many regimes for analgesia have been proposed, with analgesics being administered before or during the procedure, together with procedural sedation or even general anesthesia [42][43][44].…”

Section: Uterine Artery Embolizationmentioning

confidence: 99%

Regional anesthesia outside the operating room

Buck

Devroe²,

Missant³

et al. 2012

Current Opinion in Anaesthesiology

View full text Add to dashboard Cite

show abstract

Pain Management During Uterine Artery Embolization for Symptomatic Uterine Fibroids

Cited by 13 publications

References 7 publications

Remifentanil patient-controlled analgesia effect-site target-controlled infusion compared with morphine patient-controlled analgesia for treatment of acute pain after uterine artery embolization

Remifentanil patient-controlled analgesia effect-site target-controlled infusion compared with morphine patient-controlled analgesia for treatment of acute pain after uterine artery embolization

Significance of changes in inflammatory parameters following uterine artery embolization in pre‑menopausal females

Regional anesthesia outside the operating room

Contact Info

Product

Resources

About